Ipca Laboratories has completed an open offer for another slice of Unichem, following a recent deal to acquire a third of the company.
Ipca Laboratories has acquired a further 19.29% stake in its fellow Indian firm Unichem for INR5.98bn ($71.9m), taking its holding in the company north of 50% and making it an official Ipca subsidiary.
The change in ownership follows Ipca earlier this year buying a 33
A free trade agreement struck between the UK and India could over “significant benefits for the generic and biosimilar sectors,” Medicines UK believes. The off-patent industry association has also suggested further avenues for collaboration between the two governments on regulatory pathways and supply security.
Niche generics company Aspire Pharma has struck a deal to acquire a portfolio of products from fellow UK firm Tetris Pharma as it is wound up, paying Tetris parent Arecor £0.5m for UK distribution rights and inventory.
Apotex has expanded an alliance formed with Formosa in August for its novel clobetasol propionate ophthalmic treatment, adding Mexican rights to its existing deal for the Canadian market.
Adalvo and Gedeon Richter have announced a global co-development deal for semaglutide for obesity. Adalvo CEO Anil Okay spoke to Generics Bulletin about the alliance as well as the broader competitive landscape for GLP-1s.
